Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance

European Journal of Medical Research

Volumn 15, Issue 2, 2010, Pages 123-127

  Popko, K ^a   Gorska, E ^a   Demkow, U ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

gene polymorphism; IL 6; obesity

Indexed keywords

CYSTEINE; GLYCINE; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ENERGY BALANCE; ENERGY EXPENDITURE; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; IL 6 GENE; NONHUMAN; OBESITY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMISTRY; ENERGY METABOLISM; GENETICS; GENOTYPE; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GENOTYPE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-6;

EID: 79952276637     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-15-S2-123     Document Type: Review

References (52)

1. May LT, Ghrayeb J, Santhanam U, Tatter SB, Sthoeger Z, Helfgott DC, Chiorazzi N, Grieninger G, Sehgal PB: Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem 1988, 263: 7760-6.
2. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutanous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vitro. J Clin Endocrinol Metab 1997, 82: 4196-200. 10.1210/jc.82.12.4196
3. Vgontzas AN, Papanicolaou DA, Bixler DA, Kales A, Tyson K, Chrousos GP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997, 82: 1313-6. 10.1210/jc.82.5.1313
4. Fried SK, Bunkin DA, Greengerg AS: Omental and subcutaneous adipose tissue of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83: 847-50. 10.1210/jc.83.3.847
5. Grunfeld C, Feingold KR: The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991, 3: 143-58. 10.1007/BF02172087
6. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T: Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986, 324: 73-76. 10.1038/324073a0
7. Pickup JC, Mattock MB, Chusney GD, Burt D: NIDDM as a disease of the innate immune system: Association of acute-phase reactans and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40: 1286-92. 10.1007/s001250050822
8. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK: Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 2001, 537: 633-9. 10.1111/j.1469-7793.2001.00633.x
9. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988, 332: 83-5. 10.1038/332083a0
10. Filella X, Blade J, Montoto S, Molina R, Coca F, Montserrat E, Ballesta AM: Impaired production of interleukin-6 and tumour necrosis factor alpha in whole blood cell cultures of patients with multiple myeloma. Cytokine 1998, 10: 993-6. 10.1006/cyto.1998.0387
11. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH: Direct antidiabetic effect of leptin trough triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997, 94: 4637-41. 10.1073/pnas.94.9.4637
12. Stunkard AJ: An adoption study of human obesity. N Engl J Med 1986, 314: 193-8. 10.1056/NEJM198601233140401
13. White DW, Wang Y, Chua SC: Constitutive and impaired signalling of leptin receptors containing the Gln →Pro extracellular domain fatty mutation. Proc Natl Acad Sci USA 1997, 94: 10657-62. 10.1073/pnas.94.20.10657
14. Gotoda T, Manning BS, Goldstone AP: Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet 1997, 6: 869-876. 10.1093/hmg/6.6.869
15. Wu DM, Shen MH, Chu NF: Relationship between plasma leptin levels and lipid profiles among school children in Taiwan-the Taipei Children Heart Study. Eur J Epidemiol 2001, 17: 911-6. 10.1023/A:1016280427032
16. Kroder G, Bassenmaier B, Kellerer M, Capp E, Stoyanov B, Muhlhofer A, Berti L, Horikoshi H, Ulrich A, Haring H: Tumor necrosis factor alpha and hyperglycemia-induced insulin resistance: evidence for different mechanism and different effects on insulin signaling. J Clin Invest 1996, 97: 1471-7. 10.1172/JCI118569
17. Van Damme J, Van Beeumen J, Decock B, Van Snick J, De Ley M, Billiau A: Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6. J Immunol 1988, 140: 1534-41.
18. Breton J, la Fiura A, Bertolero F, Orsini G, Valsasina B, Ziliotto R, de Filippis V, Polverino de Laureto P, Fontana A: Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond. Eur J Biochem 1995, 227: 573-81. 10.1111/j.1432-1033.1995.tb20427.x
19. Somers W, Stahl M, Seehra JS: 1.9 A crystal structure of interleukin-6: implications for a novel mode of receptor dimerization and signaling. EMBO 1997, 16: 989-97. 10.1093/emboj/16.5.989
20. Simpson RJ, Hammacher A, Smith DK, Matthews JM, Ward LD: Interleukin-6: Structure-function relationships. Protein Sci 1997, 6: 929-55. 10.1002/pro.5560060501
21. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T: Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988, 241: 825-8. 10.1126/science.3136546
22. Ihle JN, Kerr IM: Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 1995, 11: 69-74. 10.1016/S0168-9525(00)89000-9
23. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989, 58: 573-81. 10.1016/0092-8674(89)90438-8
24. Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H, Taga T, Kishimoto T: Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL-6 receptor, and establishment of an ELISA for soluble gp130. Immunol Lett 1992, 31: 123-30. 10.1016/0165-2478(92)90138-E
25. Ray A, Prefontaine KE, Ray P: Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994, 269: 12940-6.
26. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL: Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Met 2003, 88: 255-9. 10.1210/jc.2002-020092
27. Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M: Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: The Finnish Diabetes Prevention Study. Diabetes 2003, 52: 1872-6. 10.2337/diabetes.52.7.1872
28. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson J-O: Interleukin-6 deficient mice develop mature-onset obesity. Nature Med 2002, 8: 75-9. 10.1038/nm0102-75
29. Plata-Salaman CR: Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000, 16: 1009-12. 10.1016/S0899-9007(00)00413-5
30. Tsigos C, Papanicolaou DA, Defensor R, Mitsidis CS, Kyrou I, Chrousos GP: Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997, 66: 54-62. 10.1159/000127219
31. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 2000, 43: 872-880. 10.1002/1529-0131(200004)43:4<872::AID-ANR19>3.0.CO;2-T
32. Fernandes-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W: Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001, 86: 1154-9. 10.1210/jc.86.3.1154
33. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP: Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with cate-cholamines. Am J Physiol 1996, 271: E601-5.
34. Marz P, Cheng JG, Gadient RA, Patterson PH, Stovan T, Otten U, Rose-John S: Sympathetic neurons can produce and respond to interleukin-6. Proc Natl Acad Sci USA 1998, 95: 3251-6. 10.1073/pnas.95.6.3251
35. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995, 268: E813-9.
36. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leiber RL: Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002, 87: 2391-4. 10.1210/jc.87.5.2391
37. Pedersen BK, Hoffman-Goetz L: Exercise and the immune system: Regulation, integration and adoption. Physiol Rev 2000, 80: 1055-81.
38. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Pedersen BK: Production of IL-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma IL-6. J Physiol 2000, 529: 237-42. 10.1111/j.1469-7793.2000.00237.x
39. Nybo L, Nielsen B, Pedersen BK, Moller K, Secher NH: Interleukin-6 release from the human brain during prolonged exercise. J Physiol 2002, 542: 991-5. 10.1113/jphysiol.2002.022285
40. Langberg H, Olesen J, Gemmer C, Kiaer M: Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 2002, 542: 985-90. 10.1113/jphysiol.2002.019141
41. Lyngso D, Simonsen L, Bulow J: Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 2002, 543: 373-8. 10.1113/jphysiol.2002.019380
42. Ostrowski K, Rodher T, Zacho M, ASP S, Pedersen BK: Evidence that interleukin-6 produced in human skeletal muscle during prolonged running. J Physiol 1998, 508: 949-53. 10.1111/j.1469-7793.1998.949bp.x
43. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, Neufer PD: Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 2001, 15: 2748-50.
44. Helge JW, Stallknecht B, Pedersen BK, Galbo H, Kiens B, Richter EA: The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J Physiol 2003, 546: 299-305. 10.1113/jphysiol.2002.030437
45. Keller C, Keller P, Marshal S, Pedersen BK: IL-6 gene expression in human adipose tissue in response to exercise-effect of carbohydrate ingestion. J Physiol 2003, 550: 927-31. 10.1113/jphysiol.2003.044883
46. Jonsson A, Wales JK: Blood glycoprotein levels in diabetes mellitus. Diabetologia 1976, 12: 245-50.
47. McMillan DE: Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989, 38: 1042-6. 10.1016/0026-0495(89)90038-3
48. Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, Ricart W, Vwndrell J, Richart C, Tataranni PA, Wolford JK: The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum-Genet 2003, 112: 409-13.
49. Mohlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, Bergmann MM, Ristow M, Hoffmann K, Pfeiffer AF: Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 2004, 89: 1885-90. 10.1210/jc.2003-031101
50. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W: Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 2000, 49: 517-20. 10.2337/diabetes.49.3.517
51. Illing T, Bongardt F, Schopfer A, Muller-Scholce S, Rathmann W, Koenig W, Thorand B, Vollmert C, Holle R, Kolb H, Herder C: Significant association of the interleukin-6 gene polymorphism C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 2004, 89: 5053-8. 10.1210/jc.2004-0355
52. Popko K, Gorska E, Stelmaszczyk-Emmel A, Wisniewska A, Majcher A, Wasik M, Demkow U: Influence of proinflammatory cytokine gene polymorphism on childhood obesity. Eur J Med Res 2009,14(Supp 4):59-62.